The value of age IgG and IL6 in estimating time of viral clearance in asymptomatic or mild patients with COVID-19

被引:0
作者
Cao, Xi [1 ]
Xie, Yong-Li [2 ,3 ]
Zhou, Chun-lei [1 ]
Mu, Hong [1 ]
机构
[1] Tianjin First Cent Hosp, Dept Clin Lab, Tianjin, Peoples R China
[2] Nankai Univ, Tianjin Stomatol Hosp, Sch Med, Dept Clin Lab, Tianjin, Peoples R China
[3] Tianjin Key Lab Oral & Maxillofacial Funct Reconst, Tianjin, Peoples R China
关键词
COVID-19; RT-PCR; nucleic acid clearance; IgG; IL6;
D O I
10.3389/fmicb.2023.1256759
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The aim of this study was to investigate the relationship between Age, immunoglobin G (IgG), immunoglobin M (IgM), procalcitonin (PCT), and interleukin-6 (IL6), and the time to clear viral nucleic acids in asymptomatic and mild coronavirus disease 2019 (COVID-19) patients, as well as evaluated the predictive value of these biochemical indicators. Methods: We performed a retrospective analysis on 1,570 individuals who were admitted to Tianjin First Central Hospital and diagnosed with asymptomatic or mild cases. Laboratory data were collected, including age, gender, levels of IgG, IgM, PCT and IL6, as well as results of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) nucleic acid test. These data were statistically analyzed using SPSS software, version 24.0. Results: The results indicated that among mild patients, Age, IgG, and the time to clear viral nucleic acids were higher than asymptomatic patients (p < 0.05). And the time to clear viral nucleic acids was significantly correlated with Age, IgG, IgM, PCT, and IL6 (p < 0.05), IgG (r = -0.445, p < 0.001) showed moderate correlations. Using logistic regression analysis, we identified older age, high IL6 levels, and low IgG levels were risk factors for nucleic acid clearance exceeding 14 days (p < 0.05). When combining these three indicators to predict the probability of nucleic acid clearance exceeding 14 days in the 1,570 patients, the AUROC was found to be 0.727. Conclusion: Age, IgG, and IL6 could potentially serve as useful predictors for nucleic acid clearance exceeding 14 days in asymptomatic and mild COVID-19 patients.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Effect of methylprednisolone therapy on hospital stay and viral clearance in patients with moderate COVID-19
    Li, Xiaoyan
    Yuan, Xin
    Xu, Zhe
    Huang, Lei
    Shi, Lei
    Lu, Xuechun
    Wang, Fu-Sheng
    Fu, Junliang
    INFECTIOUS MEDICINE, 2022, 1 (04): : 236 - 244
  • [42] Role of SNPs of IL6 gene in the incidence and progression of COVID19 patients in Wasit province
    Mahmood, Ayat Ali
    Gheni, Doaa Alaa
    Ibrahim, Mohammed Ismael
    Abdullabass, Hasaneen Kudhair
    Hayyawi, Aws Raiad
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 537 - 545
  • [43] Investigation of Genetic Variations of IL6 and IL6R as Potential Prognostic and Pharmacogenetics Biomarkers: Implications for COVID-19 and Neuroinflammatory Disorders
    Strafella, Claudia
    Caputo, Valerio
    Termine, Andrea
    Barati, Shila
    Caltagirone, Carlo
    Giardina, Emiliano
    Cascella, Raffaella
    LIFE-BASEL, 2020, 10 (12): : 1 - 10
  • [44] Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits
    Al-Jighefee, Hadeel T.
    Yassine, Hadi M.
    Al-Nesf, Maryam A.
    Hssain, Ali A.
    Taleb, Sara
    Mohamed, Ahmed S.
    Maatoug, Hassen
    Mohamedali, Mohamed
    Nasrallah, Gheyath K.
    PATHOGENS, 2021, 10 (02): : 1 - 18
  • [45] IL-6 Serum Levels in COVID-19 Patients With Vertigo
    Kitsos, Dimitrios
    Tzartos, John
    Korres, George
    Giannopapas, Vasileios
    Riga, Maria
    Stergiou, Christos
    Tsoga, Anthi
    Grigoropoulos, Christos
    Paraskevas, Georgios
    Zompola, Christina
    Nikolopoulos, Thomas
    Giannopoulos, Sotirios
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [46] SARS-CoV-2 Viremia Precedes an IL6 Response in Severe COVID-19 Patients: Results of a Longitudinal Prospective Cohort
    Roy-Vallejo, Emilia
    Cardenoso, Laura
    Triguero-Martinez, Ana
    Chicot Llano, Marta
    Zurita, Nelly
    Avalos, Elena
    Barrios, Ana
    Hernando, Julia
    Ortiz, Javier
    Rodriguez-Garcia, Sebastian C.
    Ciudad Sanudo, Marianela
    Marcos, Celeste
    Castillo, Elena Garcia
    Garcia-Rodrigo, Leticia Fontan
    Gonzalez, Begona
    Mendez, Rosa
    Iturrate, Isabel
    Sanz-Garcia, Ancor
    Villa, Almudena
    Sanchez-Azofra, Ana
    Quicios, Begona
    Arribas, David
    Rodriguez, Jesus Alvarez
    Patino, Pablo
    Trigueros, Marina
    Uriarte, Miren
    Martin-Ramirez, Alexandra
    Roman, Cristina Arevalo
    Galvan-Roman, Jose Maria
    Garcia-Vicuna, Rosario
    Ancochea, Julio
    Munoz-Calleja, Cecilia
    Fernandez-Ruiz, Elena
    de la Camara, Rafael
    Fernandez, Carmen Suarez
    Gonzalez-Alvaro, Isidoro
    Rodriguez-Serrano, Diego A.
    PREDINMUN COVID Grp
    FRONTIERS IN MEDICINE, 2022, 9
  • [47] COVID-19 in neonates and infants younger than 6 months-a mild viral illness
    Khoury, Lana
    Pillar, Giora
    Shehadeh, Shereen
    EUROPEAN JOURNAL OF PEDIATRICS, 2023, 182 (07) : 3287 - 3291
  • [48] Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan
    Takeshita, Masaru
    Nishina, Naoshi
    Moriyama, Saya
    Takahashi, Yoshimasa
    Uwamino, Yoshifumi
    Nagata, Mika
    Aoki, Wataru
    Masaki, Katsunori
    Ishii, Makoto
    Saya, Hideyuki
    Kondo, Yasushi
    Kaneko, Yuko
    Suzuki, Katsuya
    Fukunaga, Koichi
    Takeuchi, Tsutomu
    VIROLOGY, 2021, 555 : 35 - 43
  • [49] Safety and efficacy of a Siddha Medicine fixed regimen for the treatment of asymptomatic and mild COVID-19 patients
    Kannan, M.
    Sathiyarajeswaran, P.
    Sasikumar, D.
    Geetha, A.
    Mohanapriya, M.
    Vinod, N. P.
    Manickam, P.
    Kanakavalli, K.
    Parthibhan, P.
    Kumar, M. Pitchiah
    Kannan, R.
    Sivaraman, G.
    JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2022, 13 (03)
  • [50] Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients
    Suthutvoravut, Unyaporn
    Kunakorntham, Patratorn
    Semayai, Anchisatha
    Tansawet, Amarit
    Pattanaprateep, Oraluck
    Piebpien, Pongsathorn
    Numthavaj, Pawin
    Thakkinstian, Ammarin
    Atiksawedparit, Pongsakorn
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)